Skip to main content
Springer logoLink to Springer
. 2024 May 24;41(7):3014–3015. doi: 10.1007/s12325-024-02886-x

Correction to: Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT

Dédée F Murrell 1,11,, Pascal Joly 2, Victoria P Werth 3,4, Hideyuki Ujiie 5, Margitta Worm 6, Aaron R Mangold 7, Elena Avetisova 8, Jennifer Maloney 8, Elizabeth Laws 9, Eric Mortensen 8, Ariane Dubost-Brama 10, Arsalan Shabbir 8
PMCID: PMC11213776  PMID: 38787464

Correction to: Adv Ther 10.1007/s12325-024-02810-3

In the sentence beginning ‘A Cochrane Review…’ in this article, the term TCSs should have read ‘TCS’.

In the sentence beginning ‘In clinical…’ in this article, the value ‘312’ should have read ‘2312’.

In the sentence beginning ‘Werth is a…’ in this article, the text ‘Lily’ should have read ‘Eli Lily’.

The original article has been corrected.


Articles from Advances in Therapy are provided here courtesy of Springer

RESOURCES